Tailoring of Retinyl Palmitate-Based Ethosomal Hydrogel as a Novel Nanoplatform for Acne Vulgaris Management: Fabrication, Optimization, and Clinical Evaluation Employing a Split-Face Comparative Study
Heba F Salem,Rasha M Kharshoum,Sara M Awad,Mai Ahmed Mostafa,Heba A Abou-Taleb
DOI: https://doi.org/10.2147/IJN.S301597
IF: 7.033
2021-06-24
International Journal of Nanomedicine
Abstract:Heba F Salem, 1 Rasha M Kharshoum, 1 Sara M Awad, 2 Mai Ahmed Mostafa, 3 Heba A Abou-Taleb 3 1 Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Beni-Suef University, Beni-Suef, Egypt; 2 Department of Dermatology, Venereology and Andrology, Assiut University Hospital, Assiut, Egypt; 3 Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Nahda University (NUB), Beni-Suef, Egypt Correspondence: Heba F Salem Email Aim: Retinyl palmitate (RP), the most stable vitamin A derivative, is used to treat photoaging and other skin disorders. The need to minimize the adverse effects of topical drug administration has led to an enhanced interest in loading RP on ethosomes for topical drug delivery. The aim of the current study was to prepare and compare the performance of RP decorated ethosomal hydrogel with tretinoin cream in the treatment of acne vulgaris as an approach to improve drug efficacy and decrease its side effects. Methods: RP-loaded ethosomes were prepared using the injection sonication technique. A Box–Behnken design using Design Expert ® software was used for the optimization of formulation variables. Particle size, zeta potential (ZP), entrapment efficiency percent (EE%), % drug release, and permeation over 24 h of different formulations were determined. The optimal formulation was incorporated into a hydrogel. Finally, the efficacy and tolerability of the optimized RP ethosomal hydrogel were clinically evaluated for acne treatment using a split-face comparative clinical study. Results: The optimized ethosomal RP showed particle size of 195.8± 5.45 nm, ZP of − 62.1± 2.85 mV, EE% of 92.63± 4.33%, drug release % of 96.63± 6.81%, and drug permeation % of 85.98 ± 4.79%. Both the optimized RP ethosomal hydrogel and tretinoin effectively reduced all types of acne lesions (inflammatory, non-inflammatory, and total lesions). However, RP resulted in significantly lower non-inflammatory and total acne lesion count than the marketed tretinoin formulation. Besides, RP-loaded ethosomes showed significantly improved tolerability compared to marketed tretinoin with no or minimal skin irritation symptoms. Conclusion: RP ethosomal hydrogel is considerably effective in controlling acne vulgaris with excellent skin tolerability. Therefore, it represents an interesting alternative to conventional marketed tretinoin formulation for topical acne treatment. Keywords: ethosomes, Box–Behnken design, retinyl palmitate, topical delivery, acne vulgaris Acne vulgaris is a chronic inflammatory disease of the skin affecting the pilosebaceous follicles. It commonly affects teenagers and young adults. It is characterized by dysregulated sebum production, disturbed follicular keratinization, Propionibacterium acnes colonization, inflammation, and immune responses. 1 Acne lesions can be subdivided into two major categories: inflammatory lesions, including papules, pustules, cysts, nodules; and non-inflammatory lesions (comedones). 2 , 3 Treatment strategies are based on minimizing keratinocyte hyperproliferation, seborrhea, colonization by Propionibacterium acnes, and inflammation. Topical treatment, especially topical retinoids, is the first choice in mild to moderate acne, whereas systemic therapy is used for treating moderate to severe cases. 4 International treatment guidelines emphasize the key role of topical retinoids in acne management. 5–7 Topical retinoids exert pleiotropic effects on acne; they normalize follicular keratinocyte proliferation and regulate follicular epithelial turnover, which helps extrusion of comedones and inhibit microcomedone formation. 8 Moreover, they have antimicrobial activity against the Propionibacterium acnes. 9–12 Besides, topical retinoids have anti-inflammatory properties by modulating the inflammatory mediators and inflammatory cell migration. 13 Although highly effective in treating acne, the use of retinoic acid topically is frequently accompanied by a high incidence of side effects as sunlight sensitivity, peeling, burning, pruritus, and erythema. 14 These cutaneous reactions tend to reduce patient compliance and compromise therapy. 10 , 14 Some retinoid derivatives, such as tretinoin, isotretinoin, tazarotene, and adapalene were developed to overcome these problems. However, they still cause lo -Abstract Truncated-
pharmacology & pharmacy,nanoscience & nanotechnology